CalciTech Reports Further Patent Developments.Business Editors HAMILTON, Bermuda--(BUSINESS WIRE)--Dec. 18, 2001 CalciTech (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: CLKTF; CDNX CDNX See Canadian Venture Exchange (CDNX). : CLK) announces that on 10th October, 2001 the European Patent Office has granted European Patent No.0912238 in favour of CalciTech Ltd. This patent, "Production of Powders," covers the unique technology of a powder precipitation reaction in a segmented flow tubular reactor, the so-called Bubbletube(TM). Different powders with extremely uniform particle size distribution The particle size distribution[1] ("PSD") of a powder, or granular material, or particles dispersed in fluid, is a list of values or a mathematical function that defines the relative amounts of particles present, sorted according to size. in nanocrystalline size can be produced by the Bubbletube(TM) apparatus. The European Patent Office has also announced that on 7 November 2001 the bibliographic data of the "Lime Treatment" PCT (Private Communications Technology) A protocol from Microsoft that provides secure transactions over the Web. See security protocol. application was published in the European Patent Bulletin The European Patent Bulletin is a weekly trilingual publication of the European Patent Office (EPO), generally issued every Wednesday. [1] It contains "entries made in the Register of European Patents, as well as other particulars the publication of which is prescribed under European Patent Number 1150919. This initiates the observation period after which the patent can be granted. CalciTech has now filed this patent application covering it's PCC PCC prothrombin complex concentrate. process world wide in the European and Eurasian Groups and 16 other major countries. CalciTech continues to focus on the development of its environmentally friendly technology for the production of PCC, which has potential applications in a wide range of markets. This press release contains forward-looking statements which are subject to a number of contingencies and uncertainties, including but not limited to, market acceptance for CalciTech products, manufacturing of CalciTech products in a commercial setting, obtaining adequate financing and construction management for products and obtaining appropriate permits. Such forward-looking statements are not guarantees of future performance, and are based on numerous assumptions about future conditions that could change. No Stock Exchange has reviewed or accepted responsibility for the adequacy or accuracy of this press release. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion